SEI Investments
HSTO

SEI Investments’s Histogen Inc. Common Stock HSTO Stock Holding History

SEI Investments’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-15
Closed -$17K – 3867
2018
Q1 		$17K Buy
+15
New +$16.6K ﹤0.01% 2706
2017
Q4 		– Sell
-8
Closed -$9K – 3564
2017
Q3 		$9K Buy
+8
New +$9.1K ﹤0.01% 2728

Other funds holding HSTO

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
AIM
Alambic Investment Management Belvedere, California $9.12M AUM 34.54% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return

SEI Investments's HSTO Position: Q2 2018 in Review

SEI Investments sold out of Histogen Inc. Common Stock (HSTO) in Q2 2018, closing a stake of 15 shares — an estimated $17K sold.

SEI Investments first reported a position in HSTO in Q3 2017 and held it in 2 quarters. The position peaked at $17K in Q1 2018. 61 funds tracked by Wall St. Rank hold HSTO as of Q2 2018.

  • SEI Investments reported no remaining Histogen Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • SEI Investments sold 15 Histogen Inc. Common Stock shares in Q2 2018, an estimated $17K.
  • SEI Investments first reported a position in Histogen Inc. Common Stock in Q3 2017 and held it in 2 quarters.
  • SEI Investments's Histogen Inc. Common Stock position peaked at $17K in Q1 2018.
  • 61 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q2 2018.

Based on SEI Investments's 13F filing for Q2 2018, filed 3 Aug 2018.